Cotización Pardes Biosciences, Inc.
Acciones
PRDS
US69945Q1058
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 59 | 01/01/21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30/08/23 |
Chief Operating Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 59 | 01/01/21 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 30/08/23 |
Nombre | Peso | AuM | Varia. 1 de ene. | Calificación inversor |
---|---|---|---|---|
0.00% | 17 M€ | +5,93 % | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
+9,30 % | 46,03 mil M | |
+52,73 % | 44,55 mil M | |
+7,15 % | 40,8 mil M | |
-8,78 % | 28,25 mil M | |
+18,68 % | 27,71 mil M | |
-21,92 % | 18,82 mil M | |
+14,62 % | 13,91 mil M | |
+31,85 % | 12,43 mil M | |
+4,47 % | 10,81 mil M |